Health Canada drug identification number

DIN 02231056 — HAVRIX 720 JUNIOR 720 UNIT

HAVRIX 720 JUNIOR is a suspension of Hepatitis A Virus, Inactivated marketed by GLAXOSMITHKLINE INC. The full Hepatitis A Virus, Inactivated monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02231056
Brand name
HAVRIX 720 JUNIOR
Strength
720 UNIT
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Manufacturer
GLAXOSMITHKLINE INC
Health Canada status
MARKETED
Drug class
Inactivated viral vaccine

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Hepatitis A Virus, Inactivated products

DINBrandStrengthFormManufacturerStatus
02237792 AVAXIM 160 UNIT SUSPENSION SANOFI VACCINES CANADA LTD. MARKETED
02187078 HAVRIX 1440 1440 UNIT SUSPENSION GLAXOSMITHKLINE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.